2026 Article Archive
UTSW introduces single-port robotic surgery for lung cancer
A team at UT Southwestern Medical Center is the first in North Texas to offer single-port robotic-assisted thoracoscopic lobectomy, a minimally invasive procedure for select patients with early-stage lung cancer.
Study reveals how RNA-modifying enzyme picks its targets
An RNA-modifying enzyme linked to cancer and neurological disorders selects its targets by recognizing specific RNA shapes and sequences, according to a study by UT Southwestern Medical Center researchers.
Joseph A. Hill, M.D., Ph.D., receives American Heart Association’s Gold Heart Award
Joseph A. Hill, M.D., Ph.D., Professor of Internal Medicine in the Division of Cardiology, Professor of Molecular Biology, and Director of the Harry S. Moss Heart Center at UT Southwestern Medical Center, has received the Gold Heart Award.
Eating at the right time is important for health, UTSW study shows
Cutting calories and limiting nighttime snacking is known to improve health and extend your lifespan. But would only eating during certain hours of the day have a similar effect on healthspan, or the length of time a person is healthy and free from disease?
Should patients learn they have cancer from an online portal?
The widespread use of electronic patient portals to provide quick access to test results presents healthcare professionals with an important challenge: How should new cancer diagnoses be communicated?
Steep drop in metabolic coenzyme could trigger preterm labor
Cutting calories and limiting nighttime snacking is known to improve health and extend your lifespan. But would only eating during certain hours of the day have a similar effect on healthspan, or the length of time a person is healthy and free from disease?
UTSW Research: T cells, lung health, cash support for heart patients
Researchers at UT Southwestern Medical Center have developed a computational method that reveals how immune cells navigate the complex environment inside tumors, offering insights that could inform future cancer therapies.
HHSC, UT Southwestern Medical Center celebrate opening of new psychiatric hospital in Dallas
The Texas Health and Human Services Commission (HHSC) and UT Southwestern Medical Center hosted a ribbon-cutting ceremony today to celebrate the opening of the Texas Behavioral Health Center in Dallas.
FDA expands use of kidney cancer drug developed from UTSW research
Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug.
Antibody may improve treatment response in lung cancer
An experimental antibody treatment that binds to a protein known as PCDH7 shrank tumors in preclinical models of non-small cell lung cancer (NSCLC), even those resistant to a targeted therapy, a study led by UT Southwestern Medical Center researchers showed.